TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Orifarm Generics A/S
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,224,465
|
2,937,013
|
2,356,940 |
Earnings before taxes |
121,051
|
98,428
|
255,831 |
Total assets |
2,084,970
|
1,904,158
|
1,572,045 |
Current assets |
2,009,235
|
1,837,171
|
1,510,580 |
Current liabilities |
1,322,567
|
1,278,278
|
851,207 |
Equity capital |
746,036
|
611,117
|
707,152 |
- share capital |
1,508
|
1,416
|
1,341 |
Employees (average) |
150
![]() |
150
![]() |
150 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
35.8%
|
32.1%
|
45.0% |
Turnover per employee |
21,496
|
19,580
|
15,713 |
Profit as a percentage of turnover |
3.8%
|
3.4%
|
10.9% |
Return on assets (ROA) | |||
Current ratio |
151.9%
|
143.7%
|
177.5% |
Return on equity (ROE) |
16.2%
|
16.1%
|
36.2% |
Change turnover |
95,166
|
449,412
|
1,433,629 |
Change turnover % |
3%
|
18%
|
155% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.